secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001213900-23-059815
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition enters $6.8M PIPE investment with Suma Ventures for Estrella merger
--------------------------------------------------------------------------------

- TradeUP (UPTD) signed binding PIPE term sheet with Suma Ventures to acquire $6.8M payables of Estrella prior to merger closing.
- At closing, TradeUP will issue 680,000 Class B units (common + preferred) to Suma in exchange for waiving the $6.8M indebtedness.
- Preferred stock converts six months after closing at price = max($10 - higher of closing price or 20-day VWAP, floor $4.15).
- New Estrella common stock expected to list on Nasdaq under ticker 'ESLA'; all shares subject to one-year lock-up.
- Transaction is conditioned on closing of the previously announced business combination between TradeUP and Estrella Biopharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023059815/0001213900-23-059815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023059815/ea182327-8k425_tradeup.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-059815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer